These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 32712831)
1. Adaptive T cell immunotherapy in cancer. Ti D; Bai M; Li X; Wei J; Chen D; Wu Z; Wang Y; Han W Sci China Life Sci; 2021 Mar; 64(3):363-371. PubMed ID: 32712831 [TBL] [Abstract][Full Text] [Related]
3. [T cell-based immunotherapies in solid tumors]. Baulu E; Dougé A; Chuvin N; Bay JO; Depil S Bull Cancer; 2021 Oct; 108(10S):S96-S108. PubMed ID: 34920813 [TBL] [Abstract][Full Text] [Related]
4. The role of exhaustion in CAR T cell therapy. Delgoffe GM; Xu C; Mackall CL; Green MR; Gottschalk S; Speiser DE; Zehn D; Beavis PA Cancer Cell; 2021 Jul; 39(7):885-888. PubMed ID: 34256903 [TBL] [Abstract][Full Text] [Related]
5. Unleash the power of the mighty T cells-basis of adoptive cellular therapy. Sukari A; Abdallah N; Nagasaka M Crit Rev Oncol Hematol; 2019 Apr; 136():1-12. PubMed ID: 30878123 [TBL] [Abstract][Full Text] [Related]
6. Cancer immunotherapy utilizing gene-modified T cells: From the bench to the clinic. Duong CP; Yong CS; Kershaw MH; Slaney CY; Darcy PK Mol Immunol; 2015 Oct; 67(2 Pt A):46-57. PubMed ID: 25595028 [TBL] [Abstract][Full Text] [Related]
7. Newer generations of multi-target CAR and STAb-T immunotherapeutics: NEXT CART Consortium as a cooperative effort to overcome current limitations. Martín-Antonio B; Blanco B; González-Murillo Á; Hidalgo L; Minguillón J; Pérez-Chacón G; Front Immunol; 2024; 15():1386856. PubMed ID: 38779672 [TBL] [Abstract][Full Text] [Related]
8. Adoptive CD8 Jiang X; Xu J; Liu M; Xing H; Wang Z; Huang L; Mellor AL; Wang W; Wu S Cancer Lett; 2019 Oct; 462():23-32. PubMed ID: 31356845 [TBL] [Abstract][Full Text] [Related]
9. Immunotherapy: enhancing the efficacy of this promising therapeutic in multiple cancers. Inthagard J; Edwards J; Roseweir AK Clin Sci (Lond); 2019 Jan; 133(2):181-193. PubMed ID: 30659159 [TBL] [Abstract][Full Text] [Related]
10. Adoptive T cell therapy for ovarian cancer. Gitto SB; Ihewulezi CJN; Powell DJ Gynecol Oncol; 2024 Jul; 186():77-84. PubMed ID: 38603955 [TBL] [Abstract][Full Text] [Related]
12. Advances in T-cell Immunotherapies. Stroncek DF; Reddy O; Highfill S; Panch SR Hematol Oncol Clin North Am; 2019 Oct; 33(5):825-837. PubMed ID: 31466607 [TBL] [Abstract][Full Text] [Related]
13. Tumor Secretome to Adoptive Cellular Immunotherapy: Reduce Me Before I Make You My Partner. Etxebeste-Mitxeltorena M; Del Rincón-Loza I; Martín-Antonio B Front Immunol; 2021; 12():717850. PubMed ID: 34447383 [TBL] [Abstract][Full Text] [Related]
14. Adoptive T cell therapy: Boosting the immune system to fight cancer. Leon E; Ranganathan R; Savoldo B Semin Immunol; 2020 Jun; 49():101437. PubMed ID: 33262066 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic effect of dual CAR-T targeting PDL1 and MUC16 antigens on ovarian cancer cells in mice. Li T; Wang J BMC Cancer; 2020 Jul; 20(1):678. PubMed ID: 32689954 [TBL] [Abstract][Full Text] [Related]
17. The use of endogenous T cells for adoptive transfer. Yee C Immunol Rev; 2014 Jan; 257(1):250-63. PubMed ID: 24329802 [TBL] [Abstract][Full Text] [Related]
18. Principles of adoptive T cell therapy in cancer. Met Ö; Jensen KM; Chamberlain CA; Donia M; Svane IM Semin Immunopathol; 2019 Jan; 41(1):49-58. PubMed ID: 30187086 [TBL] [Abstract][Full Text] [Related]
19. CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment. Martinez M; Moon EK Front Immunol; 2019; 10():128. PubMed ID: 30804938 [TBL] [Abstract][Full Text] [Related]
20. Chimeric antigen receptor T-cell lymphoma immunotherapy: the next questions. Salaroli A; Spilleboudt C; Bron D; Lewalle P Curr Opin Oncol; 2020 Sep; 32(5):434-441. PubMed ID: 32796231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]